Workflow
Tilray(TLRY)
icon
Search documents
Tilray(TLRY) - 2022 Q3 - Quarterly Report
2022-04-06 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation ...
Tilray(TLRY) - 2022 Q2 - Earnings Call Transcript
2022-01-10 23:35
Tilray, Inc. (NASDAQ:TLRY) Q2 2022 Earnings Conference Call January 10, 2022 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - Chairman and Chief Executive Officer Blair MacNeil - President, Canada Denise Faltischek - Head of International and Chief Strategy Carl Merton - Chief Financial Officer Conference Call Participants Vivien Azer - Cowen and Company Andrew Carter - Stifel Financial Pablo Zuanic - Cantor Fitzgerald Rupesh Parikh - Oppenheimer & Co. John Zamp ...
Tilray(TLRY) - 2022 Q2 - Quarterly Report
2022-01-10 13:38
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of ...
Tilray(TLRY) - 2022 Q1 - Quarterly Report
2021-10-07 20:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of in ...
Tilray(TLRY) - 2022 Q1 - Earnings Call Transcript
2021-10-07 19:21
Tilray, Inc. (NASDAQ:TLRY) Q1 2022 Earnings Conference Call October 7, 2021 8:30 AM ET Company Participants Irwin Simon – Chairman and Chief Executive Officer Carl Merton – Chief Financial Officer Berrin Noorata – Chief Corporate Affairs Officer Conference Call Participants Owen Bennett – Jefferies Vivien Azer – Cowen and Company Andrew Carter – Stifel John Zamparo – CIBC World Markets Michael Lavery – Piper Sandler Aaron Grey – Alliance Global Partners Pablo Zuanic – Cantor Fitzgerald Glenn Mattson – Laden ...
Tilray(TLRY) - 2021 Q4 - Earnings Call Presentation
2021-07-29 13:48
INVESTOR PRESENTATION LEADING THE GLOBAL CANNABIS INDUSTRY JULY 2021 ATILRAY DISCLAIMER 2021© TILRAY | Certain statements contained in this press release constitute "forward-looking statements" within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictions based on expectations and projections about future events and are not statements of historical fact. You can identify forward-looking statements by the use of forwa ...
Tilray(TLRY) - 2021 Q4 - Annual Report
2021-07-28 20:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-38594 TILRAY, INC. (Exact name of Registrant as specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of incorporatio ...
Tilray(TLRY) - 2021 Q4 - Earnings Call Transcript
2021-07-28 17:25
Financial Data and Key Metrics Changes - Net income rose to $33.6 million compared to a net loss of $84.3 million in the prior year [56][71] - Net revenue increased 25.3% to $142.2 million in Q4 over the prior year period [61] - Adjusted EBITDA increased to $40.8 million compared to $5.8 million in 2020, reflecting an improvement of 603% [76] - Free cash flow of $3.3 million was generated in Q4, marking a significant milestone for the company [56][73] Business Line Data and Key Metrics Changes - Cannabis revenue in Q4 was $53.7 million, up from $39.6 million in the same period of the prior year [61] - SweetWater's net revenues were $15.9 million, while Manitoba Harvest generated $5.8 million in essentially one month of activity [61] - Adjusted cannabis gross profit increased to $23.9 million in Q4 compared to $18.9 million in the prior year [64] - Adjusted beverage alcohol gross profit was $10.6 million in Q4, with a gross margin of 66.5% [68] Market Data and Key Metrics Changes - The average gross selling price of adult-use cannabis decreased to $2.98 per gram in Q4 from $3.90 per gram in the prior year [62] - The average gross selling price of medical cannabis decreased to $4.54 per gram in Q4 from $4.95 in the prior year [63] - The Canadian market share is currently at 16%, with a goal to reach 30% by fiscal year 2024 [16] Company Strategy and Development Direction - The company aims to achieve $4 billion in revenue by 2024, driven by growth in adult-use, medical cannabis, and new product offerings [8][84] - Strategic partnerships and strong relationships with provincial boards and retail partners are emphasized to drive brand loyalty and growth in Canada [19] - The company plans to leverage its international presence, particularly in Europe, to grow its medical cannabis business [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to execute on growth opportunities despite challenges posed by COVID-19 [10][11] - The reopening of markets is expected to improve sales dynamics, particularly for SweetWater [100] - Management highlighted the importance of consumer education and marketing changes in Canada to drive market share growth [95] Other Important Information - The company has a strong cash position of $488 million as of May 31, 2021, to support working capital and business plans [11][75] - The company has already achieved $35 million in synergies from the business combination, ahead of the anticipated pace [57][45] - The company is positioned to benefit from potential U.S. federal legalization, with plans to explore acquisitions in the consumer goods sector [84][104] Q&A Session Summary Question: Will there be permits issued to Tilray for continued growth and production in Germany? - Management confirmed that there are opportunities for additional tenders and production in Germany, especially with potential legalization from the Green Party [82] Question: Will SweetWater THC drinks be available in Canada, and are there plans to expand SweetWater to California? - Management stated that THC drinks will be available in Canada and that expansion into California is planned with a new facility in Fort Collins, Colorado [83] Question: How will Tilray benefit from pending federal legalization in the U.S.? - Management highlighted plans to grow through adult-use and medical cannabis, aiming for significant sales growth in the U.S. market post-legalization [84] Question: How is the company thinking about U.S. assets moving forward? - Management indicated a focus on acquiring consumer goods assets and MSOs, with a goal of achieving $1 billion to $1.5 billion in sales in the U.S. market [89][90] Question: What underpins the logic behind the 30% market share aspiration for 2024? - Management emphasized the need for increased consumer awareness, store openings, and innovation in products to achieve the market share goal [92][94]
Tilray(TLRY) - 2021 Q3 - Quarterly Report
2021-05-10 10:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 Tilray, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of inc ...
Tilray(TLRY) - 2021 Q3 - Earnings Call Transcript
2021-04-12 18:22
Aphria Inc. (APHA) Q3 2021 Earnings Conference Call April 12, 2021 9:00 AM ET Company Participants Carl Merton - Chief Financial Officer Irwin Simon - Chief Executive Officer Conference Call Participants Owen Bennett - Jefferies Andrew Carter - Stifel Financial Tamy Chen - BMO Capital Markets Aaron Gray - Alliance Global Partners Pablo Zuanic - Cantor Fitzgerald John Zamparo - CIBC World Markets Matthew Bottomley - Canaccord Genuity Michael Lavery - Piper Sandler Operator Good morning. My name is Mariama a ...